Delivery Order SPE2DB20D1100-SPE2DB25FE1N7
- Not listed
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) valued at $7,558.78 under a firm fixed-price contract. The award, issued on August 11, 2025, with completion scheduled for September 2, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location,...
- The Defense Logistics Agency awarded a delivery order valued at $14,704.98 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed price structure. This delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.49 to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract represents a specific pharmaceutical delivery under AmerisourceBergen's broader federal supply arrangements. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This contract, valued at $7,558.78 with a firm fixed price structure, represents a non-set-aside competitive award and is scheduled for completion by August 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,558.78 on August 11, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for ultimate completion on September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $14,704.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) with a completion date of September 2, 2025. This non-competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $29,409.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. The contract, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,352.49 and employs firm fixed pricing. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erleada 60 mg tablets in a quantity of 120 units. This is a firm fixed-price delivery order with a ceiling value of $7,558.78 and an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1N7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) on August 19, 2025, with a completion date of September 10, 2025. This firm fixed-price contract is being performed at the contractor's Conshohocken, Pennsylvania location and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its broader pharmaceutical supply relationship with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Erleada delivery supports the Defense Health Agency and other government healthcare systems' pharmaceutical needs, demonstrating the contractor's role as a key supplier of specialty medications and brand-name drugs across multiple therapeutic domains for federal military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/19/25 |